0474778 - ÚOCHB 2018 RIV GB eng J - Článek v odborném periodiku
Beljantseva, J. - Kudrin, P. - Jimmy, S. - Ehn, Marcel - Pohl, Radek - Varik, V. - Tozawa, Y. - Shingler, V. - Tenson, T. - Rejman, Dominik - Hauryliuk, V.
Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor.
Scientific Reports. Roč. 7, Feb 3 (2017), č. článku 41839. ISSN 2045-2322. E-ISSN 2045-2322
Grant CEP: GA ČR GA15-11711S
Institucionální podpora: RVO:61388963
Klíčová slova: antibiotics * enzymes * bacterial stringent response * small molecules
Obor OECD: Biochemistry and molecular biology
Impakt faktor: 4.122, rok: 2017
https://www.nature.com/articles/srep41839

The alarmone nucleotide (p) ppGpp is a key regulator of bacterial metabolism, growth, stress tolerance and virulence, making (p) ppGpp-mediated signaling a promising target for development of antibacterials. Although ppGpp itself is an activator of the ribosome-associated ppGpp synthetase RelA, several ppGpp mimics have been developed as RelA inhibitors. However promising, the currently available ppGpp mimics are relatively inefficient, with IC50 in the sub-mM range. In an attempt to identify a potent and specific inhibitor of RelA capable of abrogating (p) ppGpp production in live bacterial cells, we have tested a targeted nucleotide library using a biochemical test system comprised of purified Escherichia coli components. While none of the compounds fulfilled this aim, the screen has yielded several potentially useful molecular tools for biochemical and structural work.
Trvalý link: http://hdl.handle.net/11104/0271729